LALPATHLAB logo

Dr. Lal PathLabs Limited Stock Price

NSEI:LALPATHLAB Community·₹262.8b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 8 Fair Values set on narratives written by author
Create a narrative

LALPATHLAB Share Price Performance

₹3,079.60
-492.80 (-13.79%)
23.4% undervalued intrinsic discount
₹4,020.00
Fair Value
₹3,079.60
-492.80 (-13.79%)
23.4% undervalued intrinsic discount
₹4,020.00
Fair Value
Price ₹3,079.60
AnalystHighTarget ₹4,020.00
AnalystConsensusTarget ₹3,275.35
AnalystLowTarget ₹2,260.00

LALPATHLAB Community Narratives

AnalystHighTarget·
Fair Value ₹4.02k 23.4% undervalued intrinsic discount

Expanding Middle Class And Digital Health Will Boost Diagnostics

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value ₹3.28k 6.2% undervalued intrinsic discount

Ayushman Bharat And Chronic Trends Will Expand Diagnostics Access

0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AnalystLowTarget·
Fair Value ₹2.37k 30.0% overvalued intrinsic discount

Digital Health Trends Will Squeeze Margins Yet Allow Modest Recovery

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Recent LALPATHLAB News & Updates

Here's Why We Think Dr. Lal PathLabs (NSE:LALPATHLAB) Is Well Worth Watching

Sep 29
Here's Why We Think Dr. Lal PathLabs (NSE:LALPATHLAB) Is Well Worth Watching

Under The Bonnet, Dr. Lal PathLabs' (NSE:LALPATHLAB) Returns Look Impressive

Sep 01
Under The Bonnet, Dr. Lal PathLabs' (NSE:LALPATHLAB) Returns Look Impressive

Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Aug 18
Is Dr. Lal PathLabs (NSE:LALPATHLAB) Using Too Much Debt?

Dr. Lal PathLabs Limited Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next

Aug 05
Dr. Lal PathLabs Limited Just Beat EPS By 12%: Here's What Analysts Think Will Happen Next

Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Shares May Have Run Too Fast Too Soon

Jul 25
Dr. Lal PathLabs Limited's (NSE:LALPATHLAB) Shares May Have Run Too Fast Too Soon

Is Now The Time To Put Dr. Lal PathLabs (NSE:LALPATHLAB) On Your Watchlist?

Jun 24
Is Now The Time To Put Dr. Lal PathLabs (NSE:LALPATHLAB) On Your Watchlist?

Dr. Lal PathLabs (NSE:LALPATHLAB) Has Affirmed Its Dividend Of ₹6.00

Jun 03
Dr. Lal PathLabs (NSE:LALPATHLAB) Has Affirmed Its Dividend Of ₹6.00

Dr. Lal PathLabs (NSE:LALPATHLAB) Has Affirmed Its Dividend Of ₹6.00

Apr 28
Dr. Lal PathLabs (NSE:LALPATHLAB) Has Affirmed Its Dividend Of ₹6.00

Dr. Lal PathLabs Limited Key Details

₹25.3b

Revenue

₹10.6b

Cost of Revenue

₹14.7b

Gross Profit

₹9.5b

Other Expenses

₹5.1b

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
61.45
Gross Margin
57.99%
Net Profit Margin
20.29%
Debt/Equity Ratio
7.1%

Dr. Lal PathLabs Limited Competitors

 
 
 
 
 
 
 
 
 
 
 
 
View more competitors

Snowflake Analysis

Outstanding track record with flawless balance sheet.

1 Risk
2 Rewards
View Full Analysis

About LALPATHLAB

Founded
1949
Employees
4980
CEO
Shankha Banerjee
WebsiteView website
www.lalpathlabs.com

Dr. Lal PathLabs Limited operates laboratories for carrying out pathological investigations in India and internationally. The company provides pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It also offers phlebotomist training programs. The company was founded in 1949 and is based in Gurugram, India.

Market Insight

Header cover image

✨Rare Earths: Tiny Market, Outsized Influence

Richard Bowman avatarRichard Bowman
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Last Week
⚡ Utilities: Defensive Dividends Meet the AI Power Surge

⚡ Utilities: Defensive Dividends Meet the AI Power Surge

Indian Market Performance

  • 7 Days: 1.9%
  • 3 Months: -1.2%
  • 1 Year: -3.8%
  • Year to Date: 1.2%
The market has climbed 1.9% in the last 7 days, lead by the Financials sector with a gain of 2.3%. Longer term the market is actually down 3.8% over the past year. Looking forward, earnings are forecast to grow by 16% annually. Market details ›